Type I interferon pathway activation in connective tissue disease associated interstitial lung disease - Summary - MDSpire

Type I interferon pathway activation in connective tissue disease associated interstitial lung disease

  • By

  • Tobias M. Defesche

  • Thomas Koudstaal

  • Marjan A. Versnel

  • Odilia B.J. Corneth

  • Zana Brkic

  • June 11, 2026

  • 0 min

Share

Objective:

Revise to include direct attribution.

Key Findings:
  • Add citations or references to specific studies.
Interpretation:

Remove unsupported conclusions.

Limitations:
  • Expand with context from the source.
Conclusion:

Revise to reflect only what is stated in the source.

Original Source(s)

Type I interferon pathway activation in connective tissue disease associated interstitial lung disease

  • by Tobias M. Defesche, Thomas Koudstaal, Marjan A. Versnel, Odilia B.J. Corneth, Zana Brkic

  • June 11, 2026

Related Content

EULAR Updates Behçet’s Syndrome Recommendations

EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement

Organ Damage, BMI Linked to Fatigue in SLE

Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity

Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease